VBI Vaccines, Inc. revenue for the last year amounted to 8.68 M USD, the most of which — 3.60 M USD — came from its highest performing source at the moment, License. The greatest contribution to the revenue figure was made by China/Hong Kong — last year it brought VBI Vaccines, Inc. 5.58 M USD, and the year before that — 66.00 k USD.